Awen Gallimore

Has grant

Professor

Cardiff University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

The role of CCR8 in cutaneous vaccination

Open Date: 2014-04-30

Close Date: 2017-04-29

Grant: Close

Dissecting the impact of L-selectin on T lymphocyte dependent tumour immunity

Open Date: 2014-04-13

Close Date: 2017-04-12

Grant: Close

Characterisation of Positive and Negative Influences in Tumour Immunity

Open Date: 2009-05-31

Close Date: 2012-07-30

Grant: Close

Development of adenovirus type 4 vectors for immunotherapeutic application

Open Date: 2008-09-30

Close Date: 2012-01-31

Grant: Close

Cellular and Viral Immunology Resource at the Wales College of Medicine, Cardiff University

Open Date: 2006-04-22

Close Date: 2010-01-22

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

Cardiff University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Awen Gallimore

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

The link between T cell activation and development of functionally useful tumour-associated high endothelial venules

Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers

Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity

Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion.

Tumor-Associated High Endothelial Venules: Inroads Enabling Immune Control of Cancer Progression

Exploiting ECM remodelling to promote immune-mediated tumour destruction

Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity

PI3K Isoform Immunotherapy for Solid Tumours.

Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity

Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology.

Collaborators (5)

Alan Parker

Martin Scurr

Andrew Godkin

Lucy Fairclough

Richard Stanton

Make your next move.